IL6 and acute kidney injury: However, inhibition of IL-1β, IL-6, and IL-18 and neutrophils by IL-1 receptor antagonist, IL-6 (−/−) mice, IL-18 antiserum, IL-18 binding protein transgenic mice, or neutrophil-depleting antibody respectively was not sufficient to prevent cisplatin-induced AKI [44].